Efficacy and Safety of Perampanel as the First Medication for Children with Newly Diagnosed Epilepsy: A Real-World Single-Center Prospective Observational Study - Quiz - MDSpire

Efficacy and Safety of Perampanel as the First Medication for Children with Newly Diagnosed Epilepsy: A Real-World Single-Center Prospective Observational Study

  • By

  • Huang, Wenmin

  • Cao, Dezhi

  • May 6, 2026

  • 0 min

Share

Original Source(s)

Efficacy and Safety of Perampanel as the First Medication for Children with Newly Diagnosed Epilepsy: A Real-World Single-Center Prospective Observational Study

  • by Huang, Wenmin , Cao, Dezhi

  • May 6, 2026

Related Content

Clinical Spectrum, independent risk factors, and treatment outcomes of pediatric arrhythmias: a multicenter retrospective analysis in Xinjiang

Clinical outcomes of weekly adalimumab in refractory non-infectious paediatric uveitis and the role of serum drug levels and anti-adalimumab antibodies

Giant rapidly involuting congenital hemangioma in a neonate: a case report